鹭燕医药 - Financials

鹭燕医药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	20.5B	19.8B	19.5B	17.5B	15.5B	15.0B	11.5B	8.3B	7.0B	6.6B	6.3B	5.5B	4.7B	2.9B
Revenue Growth %	3.1%	2.0%	10.9%	12.9%	3.5%	30.5%	37.9%	19.4%	5.4%	5.2%	14.1%	17.8%	58.9%	--
Total Revenue	20.5B	19.8B	19.5B	17.5B	15.5B	15.0B	11.5B	8.3B	7.0B	6.6B	6.3B	5.5B	4.7B	2.9B
Cost Of Revenue	18.9B	18.3B	17.9B	16.2B	14.3B	13.8B	10.6B	7.7B	6.5B	6.1B	5.8B	5.0B	4.3B	2.7B
+Gross Profit	1.5B	1.5B	1.5B	1.4B	1.2B	1.2B	900.0M	650.0M	530.0M	528.0M	537.0M	471.0M	360.0M	234.0M
Gross Margin %	7.4%	7.6%	7.8%	7.8%	8.0%	7.8%	7.8%	7.8%	7.6%	8.0%	8.5%	8.5%	7.7%	7.9%
Total Operating Cost	20.0B	19.4B	19.0B	17.1B	15.2B	14.7B	11.2B	8.1B	6.8B	6.5B	6.2B	5.4B	4.6B	2.9B
Selling Expenses	468.0M	442.0M	433.0M	379.0M	344.0M	323.0M	217.0M	168.0M	141.0M	136.0M	156.0M	130.0M	101.0M	64.4M
Admin Expenses	321.0M	309.0M	299.0M	322.0M	282.0M	282.0M	267.0M	185.0M	145.0M	137.0M	136.0M	117.0M	84.9M	59.7M
Rd Expenses	5.8M	5.5M	4.1M	3.0M	3.9M	5.2M	2.6M	628,000	--	--	--	--	--	--
Finance Expenses	212.0M	223.0M	220.0M	191.0M	171.0M	156.0M	123.0M	75.9M	65.4M	88.7M	86.2M	65.1M	43.4M	16.1M
+Operating Income	458.0M	469.0M	466.0M	406.0M	374.0M	346.0M	261.0M	199.0M	154.0M	152.0M	146.0M	146.0M	121.0M	85.5M
Operating Margin %	2.2%	2.4%	2.4%	2.3%	2.4%	2.3%	2.3%	2.4%	2.2%	2.3%	2.3%	2.6%	2.6%	2.9%
Non Operating Income	4.5M	2.7M	4.0M	12.0M	2.2M	984,200	1.9M	3.1M	4.4M	3.6M	5.8M	1.9M	2.2M	863,100
Non Operating Expenses	9.3M	1.8M	3.9M	2.7M	4.8M	3.0M	3.1M	1.2M	1.1M	168,100	95,300	146,800	320,800	477,000
Investment Income	-18.7M	-12.2M	-6.9M	-2.1M	-2.0M	11.6M	800,700	--	-2.4M	-376,600	1.5M	--	--	203,700
Asset Disposal Income	172,300	276,000	126,700	-532,800	27,100	-117,400	-236,900	1.8M	103,300	--	--	--	--	--
Asset Impairment Loss	1.9M	2.6M	3.1M	7.1M	26.4M	18.6M	11.1M	9.0M	8.5M	3.5M	3.2M	3.2M	2.5M	3.9M
Other Income	9.6M	11.6M	8.0M	10.4M	17.8M	5.6M	7.0M	4.7M	--	--	--	--	--	--
Income Before Tax	453.0M	469.0M	466.0M	415.0M	371.0M	344.0M	260.0M	200.0M	157.0M	156.0M	152.0M	147.0M	123.0M	85.9M
Income Tax	106.0M	105.0M	115.0M	111.0M	104.0M	86.6M	75.2M	55.5M	40.7M	40.5M	40.9M	38.2M	31.9M	22.0M
+Net Income	348.0M	364.0M	351.0M	305.0M	267.0M	258.0M	185.0M	145.0M	117.0M	115.0M	111.0M	109.0M	91.4M	63.9M
Net Margin %	1.7%	1.8%	1.8%	1.7%	1.7%	1.7%	1.6%	1.7%	1.7%	1.7%	1.8%	2.0%	1.9%	2.2%
Net Income Attributable	346.0M	364.0M	345.0M	306.0M	267.0M	256.0M	180.0M	131.0M	116.0M	113.0M	109.0M	108.0M	90.5M	63.6M
Minority Interest	2.1M	964,100	5.8M	-1.3M	235,300	1.6M	4.3M	14.4M	1.2M	1.7M	1.6M	833,100	863,000	254,000
Eps Basic	0.89	0.94	0.89	0.79	0.74	0.73	0.55	0.68	0.95	1.18	1.14	1.13	0.94	0.67
Eps Diluted	--	--	--	--	0.74	0.73	0.55	0.68	0.95	1.18	1.14	1.13	0.94	0.67

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	577.0M	606.0M	594.0M	415.0M	597.0M	429.0M	517.0M	542.0M	425.0M	470.0M	580.0M	356.0M	283.0M	171.0M
Accounts Receivable	5.9B	5.6B	5.8B	5.1B	3.9B	3.6B	2.8B	2.2B	1.6B	1.8B	1.6B	1.5B	1.2B	789.0M
Notes Receivable	10.5M	--	475,000	24.4M	7.0M	--	19.4M	1.8M	829,400	23.4M	100,000	7.2M	1.2M	1.5M
Notes And Accounts Receivable	5.9B	5.6B	5.8B	5.1B	3.9B	3.6B	2.8B	2.2B	1.6B	1.8B	1.6B	1.5B	1.2B	791.0M
Prepayments	307.0M	315.0M	629.0M	355.0M	332.0M	364.0M	281.0M	298.0M	117.0M	99.8M	82.3M	82.0M	74.9M	36.6M
Inventory	2.9B	2.6B	2.5B	2.3B	2.0B	1.8B	1.3B	1.1B	748.0M	570.0M	529.0M	470.0M	426.0M	222.0M
Total Current Assets	9.9B	9.3B	9.7B	8.3B	7.2B	6.3B	5.0B	4.3B	3.0B	3.0B	2.9B	2.5B	2.0B	1.2B
Long Term Equity Investment	48.1M	43.6M	33.9M	31.0M	--	--	--	--	--	--	--	--	--	--
Fixed Assets	--	917.0M	819.0M	807.0M	788.0M	640.0M	524.0M	483.0M	325.0M	312.0M	311.0M	257.0M	126.0M	65.1M
Fixed Assets Total	1.3B	917.0M	819.0M	807.0M	788.0M	640.0M	524.0M	483.0M	325.0M	312.0M	311.0M	257.0M	126.0M	65.1M
Construction In Progress	--	617.0M	509.0M	140.0M	57.1M	104.0M	99.8M	72.0M	77.1M	5.6M	6.9M	23.6M	21.5M	601,500
Construction In Progress Total	471.0M	617.0M	509.0M	140.0M	57.1M	104.0M	99.8M	72.0M	77.1M	5.6M	6.9M	23.6M	21.5M	601,500
Intangible Assets	361.0M	355.0M	177.0M	168.0M	113.0M	117.0M	108.0M	82.2M	60.1M	61.7M	62.4M	33.2M	15.7M	15.5M
Long Term Deferred Expenses	29.0M	28.6M	29.0M	32.8M	33.7M	36.0M	40.5M	35.3M	22.2M	16.7M	13.5M	6.3M	5.2M	3.5M
Total Non Current Assets	2.8B	2.5B	2.0B	1.7B	1.4B	1.2B	1.1B	853.0M	528.0M	442.0M	437.0M	373.0M	185.0M	94.7M
Total Assets	12.6B	11.8B	11.8B	10.0B	8.6B	7.5B	6.1B	5.1B	3.5B	3.4B	3.3B	2.8B	2.2B	1.3B
Short Term Borrowings	3.9B	4.0B	4.5B	4.1B	3.4B	3.1B	2.1B	1.7B	901.0M	1.1B	1.1B	910.0M	546.0M	272.0M
Accounts Payable	2.4B	2.3B	2.3B	1.8B	1.6B	1.6B	1.3B	1.1B	911.0M	1.1B	1.1B	1.0B	777.0M	577.0M
Advance Receipts	179,200	23,400	26,600	98,200	139,000	37.9M	22.5M	35.4M	500,300	3.4M	2.4M	6.0M	9.7M	2.1M
Contract Liabilities	30.5M	22.4M	31.8M	10.5M	18.6M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	8.6B	8.0B	8.3B	7.0B	5.9B	5.5B	4.2B	3.4B	2.1B	2.7B	2.6B	2.2B	1.8B	972.0M
Long Term Borrowings	648.0M	579.0M	472.0M	223.0M	111.0M	117.0M	119.0M	48.8M	15.7M	16.7M	13.8M	13.8M	--	--
Total Non Current Liabilities	841.0M	790.0M	692.0M	417.0M	213.0M	143.0M	202.0M	171.0M	24.1M	20.7M	18.1M	17.5M	681,300	819,100
Total Liabilities	9.4B	8.8B	9.0B	7.4B	6.1B	5.7B	4.4B	3.6B	2.1B	2.7B	2.7B	2.3B	1.8B	973.0M
Paid In Capital	389.0M	389.0M	389.0M	389.0M	389.0M	327.0M	192.0M	128.0M	128.0M	96.1M	96.1M	96.1M	96.1M	96.1M
Capital Reserve	618.0M	631.0M	654.0M	656.0M	752.0M	460.0M	590.0M	650.0M	650.0M	141.0M	141.0M	144.0M	144.0M	142.0M
Surplus Reserve	199.0M	199.0M	185.0M	156.0M	127.0M	87.2M	74.4M	62.4M	50.8M	38.1M	28.6M	20.7M	13.1M	9.1M
Retained Earnings	2.0B	1.7B	1.5B	1.3B	1.1B	915.0M	711.0M	632.0M	539.0M	462.0M	377.0M	294.0M	193.0M	107.0M
Minority Equity	29.7M	30.7M	69.8M	68.5M	66.0M	96.3M	84.2M	92.6M	8.0M	8.4M	7.0M	4.1M	2.4M	876,500
Equity Attributable	3.2B	2.9B	2.7B	2.5B	2.4B	1.8B	1.6B	1.5B	1.4B	738.0M	642.0M	554.0M	446.0M	354.0M
Total Equity	3.2B	3.0B	2.8B	2.6B	2.4B	1.9B	1.7B	1.6B	1.4B	746.0M	649.0M	558.0M	448.0M	355.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	22.2B	22.1B	20.8B	18.1B	16.7B	16.0B	12.8B	9.4B	8.1B	7.3B	6.9B	5.9B	4.9B	3.2B
Tax Refunds Received	524,100	4.5M	10.9M	--	1.6M	13,600	--	--	--	--	787,000	236,300	--	--
Total Operating Cash Inflow	22.3B	22.1B	21.0B	18.4B	17.0B	16.2B	13.1B	9.4B	8.1B	7.4B	7.0B	5.9B	5.0B	3.2B
Cash Paid For Goods	20.6B	19.6B	19.6B	17.5B	15.9B	15.8B	12.1B	9.3B	7.8B	6.9B	6.3B	5.6B	4.8B	3.0B
Cash Paid To Employees	560.0M	539.0M	505.0M	468.0M	402.0M	369.0M	296.0M	203.0M	166.0M	155.0M	146.0M	117.0M	91.1M	68.3M
Taxes Paid	385.0M	382.0M	365.0M	343.0M	283.0M	265.0M	215.0M	150.0M	131.0M	133.0M	141.0M	127.0M	85.4M	56.1M
Total Operating Cash Outflow	21.8B	20.8B	20.7B	18.7B	17.0B	16.9B	13.0B	9.9B	8.2B	7.4B	6.8B	6.0B	5.0B	3.2B
Operating Cash Flow	577.0M	1.3B	232.0M	-372.0M	60.4M	-629.0M	127.0M	-445.0M	-128.0M	219,300	178.0M	-76.5M	-32.9M	28.0M
Total Investing Cash Inflow	442,900	7.9M	450,300	6.4M	2.7B	2.6B	1.2B	2.7M	11.0M	-171,100	15.6M	117,200	78,400	694,000
Total Investing Cash Outflow	370.0M	542.0M	330.0M	280.0M	2.9B	2.9B	1.6B	288.0M	110.0M	42.3M	86.9M	170.0M	91.6M	43.1M
Investing Cash Flow	-370.0M	-534.0M	-329.0M	-273.0M	-179.0M	-226.0M	-392.0M	-286.0M	-99.2M	-42.5M	-71.2M	-170.0M	-91.5M	-42.4M
Cash From Borrowings	8.9B	8.9B	8.7B	6.7B	5.4B	4.9B	3.6B	2.5B	2.8B	3.1B	2.9B	2.7B	1.6B	623.0M
Dividends And Interest Paid	325.0M	350.0M	336.0M	253.0M	234.0M	185.0M	177.0M	99.0M	92.3M	95.2M	93.9M	58.1M	37.5M	40.1M
Debt Repayments	8.9B	9.2B	8.1B	5.8B	5.1B	3.9B	3.1B	1.7B	3.0B	3.0B	2.7B	2.3B	1.3B	552.0M
Total Financing Cash Inflow	8.9B	9.0B	8.7B	6.7B	5.7B	4.9B	3.6B	2.6B	3.3B	3.1B	2.9B	2.7B	1.6B	644.0M
Total Financing Cash Outflow	9.3B	9.7B	8.5B	6.2B	5.4B	4.2B	3.4B	1.9B	3.2B	3.1B	2.8B	2.4B	1.3B	592.0M
Financing Cash Flow	-329.0M	-709.0M	184.0M	476.0M	313.0M	748.0M	205.0M	769.0M	180.0M	-67.6M	117.0M	306.0M	242.0M	52.0M
Net Change In Cash	-121.0M	66.7M	89.9M	-170.0M	193.0M	-107.0M	-59.6M	37.5M	-46.4M	-109.0M	224.0M	59.0M	117.0M	37.6M
Ending Cash Balance	341.0M	462.0M	395.0M	305.0M	475.0M	281.0M	388.0M	447.0M	410.0M	456.0M	566.0M	342.0M	283.0M	166.0M
Capex	361.0M	529.0M	328.0M	243.0M	171.0M	199.0M	134.0M	84.2M	110.0M	42.3M	85.1M	137.0M	85.5M	34.1M